Fenofibrate and Atrioventricular block first degree - a phase IV clinical study of FDA data

Summary:

Atrioventricular block first degree is reported as a side effect among people who take Fenofibrate (fenofibrate), especially for people who are male, 60+ old, also take Lantus, and have Suicide attempt.

The phase IV clinical study analyzes which people have Atrioventricular block first degree when taking Fenofibrate. It is created by eHealthMe based on reports of 39,402 people who have side effects when taking Fenofibrate from the FDA, and is updated regularly.

What is Fenofibrate?

Fenofibrate has active ingredients of fenofibrate. It is often used in high blood cholesterol. eHealthMe is studying from 40,456 Fenofibrate users. Check the latest studies of Fenofibrate.

What is Atrioventricular block first degree?

Atrioventricular block first degree (heart block first degree) is found to be associated with 648 drugs and 890 conditions by eHealthMe. Check the latest studies of Atrioventricular block first degree.

On Jul, 06, 2026

39,402 people reported to have side effects when taking Fenofibrate.
Among them, 22 people (0.06%) have Atrioventricular block first degree.

Could Fenofibrate cause Atrioventricular block first degree?

Among these 22 people:

What is the gender of people who have Atrioventricular block first degree when taking Fenofibrate? *

female: 47.62 %
male: 52.38 %

What is the age of people who have Atrioventricular block first degree when taking Fenofibrate? *

What are other drugs people take besides Fenofibrate? *

What are other side effects people have besides Atrioventricular block first degree? *

Hypovolaemic Shock (shock caused by severe blood or fluid loss): 7 people, 31.82%
Miosis (constriction of the pupil of the eye, resulting from a normal response to an increase in light): 7 people, 31.82%
Consciousness - Decreased: 7 people, 31.82%
Hypotension (abnormally low blood pressure): 5 people, 22.73%
Stress And Anxiety: 4 people, 18.18%
Joint Pain: 4 people, 18.18%
Hyperkalemia (damage to or disease of the kidney): 4 people, 18.18%
Chest Pain: 4 people, 18.18%
Cardiac Failure Congestive: 4 people, 18.18%
Weakness: 4 people, 18.18%

What are the existing conditions these people have? *

Suicide Attempt: 4 people, 18.18%
Prostate Cancer Metastatic: 3 people, 13.64%
Wheezing (a high-pitched whistling sound made while you breath): 1 person, 4.55%
Urinary Tract Infection: 1 person, 4.55%
Relapsing-Remitting Multiple Sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged): 1 person, 4.55%
Rashes (redness): 1 person, 4.55%
Oedema (fluid collection in tissue): 1 person, 4.55%
Nausea And Vomiting: 1 person, 4.55%
Nausea (feeling of having an urge to vomit): 1 person, 4.55%
Multiple Myeloma (cancer of the plasma cells): 1 person, 4.55%

* Approximation only. Some reports may have incomplete information.

Do you take Fenofibrate and have Atrioventricular block first degree?

- Check whether Atrioventricular block first degree is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Fenofibrate:

Fenofibrate (40,456 reports)

Browse all side effects of Fenofibrate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Atrioventricular block first degree:

Atrioventricular block first degree (648 drugs)

Browse all the conditions that are associated with Atrioventricular block first degree:

Atrioventricular block first degree (890 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fenofibrate (the active ingredients of Fenofibrate) and Fenofibrate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.